SCHEMBL4356744

SCHEMBL4356744

N/C=C(\N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1251650 1.00
Formic Acid SCHEMBL28342255 0.91 LDHA (0.37)
SCHEMBL19020903 0.76
SCHEMBL3193855 0.74
SCHEMBL560165 0.74
SCHEMBL13452281 0.74
SCHEMBL360722 0.71
SCHEMBL28581725 0.71
SCHEMBL5075041 0.71
SCHEMBL1223513 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443204-B1 COATING COMPOSITIONS INCLUDING CERAMIC PARTICLES AIRBUS SAS (FR) 2019-08-07 EP claimed
EP-2488300-B1 PROCESS FOR PRODUCING POSITIVELY CHARGED POLYMER ENCAPSULATED PARTICLES HEWLETT PACKARD DEVELOPMENT CO (US) 2016-02-24 EP claimed
EP-1951440-B1 MICROWAVE PROCESS FOR POROUS CERAMIC FILTERS WITH PASSIVATION AND CATALYST COATINGS CORNING INC (US) 2013-07-10 EP claimed
EP-1663515-B1 POROUS CERAMIC FILTERS WITH CATALYST COATINGS CORNING INC (US) 2013-06-19 EP claimed
EP-1311572-B1 BIOCIDAL POLYURETHANE COMPOSITIONS AND METHOD OF USE 3M INNOVATIVE PROPERTIES CO (US) 2011-12-21 EP claimed
EP-0822838-B1 Process for making biocidal surface films NOVAPHARM RES AUSTRALIA (AU) 2004-06-23 EP claimed
EP-3158008-B2 MULTIFUNCTIONAL ACRYLIC OLIGOMERS OF BRANCHED STRUCTURE, BY POLYADDITION BETWEEN MULTIFUNCTIONAL AMINES AND ACRYLATES ARKEMA FRANCE (FR) 2023-05-17 EP disclosed
CN-114134095-B Method for producing L-lysine and/or 1, 5-pentanediamine by using halophilic bacteria 清华大学 2022-06-17 CN disclosed
CN-114134095-A Method for producing L-lysine and/or 1, 5-pentanediamine by using halophilic bacteria 清华大学 2022-03-04 CN disclosed
WO-2021222404-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 JANSSEN BIOTECH, INC. (US) 2021-11-04 WO disclosed
EP-3207078-B1 NON-ISOCYANATE URETHANE MONO- OR MULTIACRYLATE OLIGOMERS ARKEMA FRANCE (FR) 2021-10-13 EP disclosed
WO-2021129602-A1 SUBSTITUTED POLYCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 石家庄迪斯凯威医药科技有限公司 2021-07-01 WO disclosed
EP-3822272-A1 FUSED TRI-CYCLIC COMPOUND AS PDE3/PDE4 DUAL INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-05-19 EP disclosed
EP-1987015-A2 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2008-11-05 EP disclosed
EP-1935399-A2 Cosmetic product containing silicone compounds and an amphiphilic polymer L'OREAL (FR) 2008-06-25 EP disclosed
WO-2007093529-A2 HETEROAROYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-08-23 WO disclosed
WO-2007093539-A2 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-08-23 WO disclosed
WO-2005049019-A1 N-HETEROARYL INDOLE CARBOXAMIDES AND ANALOGUES THEREOF, FOR USE AS GLUCOKINASE ACTIVATORS IN THE TREATMENT OF DIABETES NOVO NORDISK A/S (DK) 2005-06-02 WO disclosed
US-4136187-A CORONARY VESSEL DILATORS BAYER AKTIENGESELLSCHAFT (DE) 1979-01-23 US disclosed
US-3959292-A HYPOTENSIVE AGENTS, CORONARY DILATORS BAYER AKTIENGESELLSCHAFT (DT) 1976-05-25 US disclosed